The store will not work correctly when cookies are disabled.
7-(4-(naphthalen-1-yloxy)butoxy)-4H-chromen-4-one
ID: ALA5178111
PubChem CID: 168277843
Max Phase: Preclinical
Molecular Formula: C23H20O4
Molecular Weight: 360.41
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=c1ccoc2cc(OCCCCOc3cccc4ccccc34)ccc12
Standard InChI: InChI=1S/C23H20O4/c24-21-12-15-27-23-16-18(10-11-20(21)23)25-13-3-4-14-26-22-9-5-7-17-6-1-2-8-19(17)22/h1-2,5-12,15-16H,3-4,13-14H2
Standard InChI Key: KYRCRGJARGUGEX-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
-4.6207 0.0030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9062 0.4153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1943 0.0034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1943 -0.8217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9044 -1.2335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6207 -0.8254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4851 -1.2300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4833 -2.0510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1888 -2.4622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9026 -2.0578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4832 0.4140 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7722 0.0034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0611 0.4140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3500 0.0034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3609 0.4140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0720 0.0034 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.7831 0.4140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7833 1.2351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4926 1.6437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2039 1.2330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2055 0.4161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4972 0.0017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9088 1.6412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6174 1.2342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6207 0.4213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9170 0.0074 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9088 2.4622 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
4 7 1 0
8 7 2 0
9 8 1 0
10 9 2 0
5 10 1 0
3 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
18 17 2 0
19 18 1 0
20 19 2 0
21 20 1 0
22 21 2 0
17 22 1 0
20 23 1 0
24 23 1 0
25 24 2 0
26 25 1 0
21 26 1 0
23 27 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 360.41 | Molecular Weight (Monoisotopic): 360.1362 | AlogP: 5.18 | #Rotatable Bonds: 7 |
Polar Surface Area: 48.67 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 4.72 | CX LogD: 4.72 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.43 | Np Likeness Score: -0.15 |
References
1. Gupta O, Pradhan T, Bhatia R, Monga V.. (2021) Recent advancements in anti-leishmanial research: Synthetic strategies and structural activity relationships., 223 [PMID:34171661] [10.1016/j.ejmech.2021.113606] |